Effects of Different Ventilatory Strategy During Bronchoscopy
NCT ID: NCT05956301
Last Updated: 2023-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2023-07-20
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our study aim was to evaluate the efficacy and complications of High-flow nasal oxygen (HFNO) via Supraglottic jet oxygenation and ventilation (SJOV)during flexible bronchoscopy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy
NCT05298319
Interventional Bronchoscopy Under Noninvasive Ventilation
NCT02289586
High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy
NCT01650974
Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments
NCT06970990
Changes in Lung Aeration and Inspiratory Effort With and Without Awake Prone
NCT05719103
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
Conventional Oxygen Therapy
Conventional Oxygen Therapy
Conventional Oxygen Therapy will be administered through Nasal catheter
Group II
High-flow nasal oxygen
High-flow nasal oxygen
High Flow Nasal Cannula will be administered
Group III
Supraglottic jet oxygenation and ventilation
Supraglottic jet oxygenation and ventilation
Nasal jet tube will be administered
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conventional Oxygen Therapy
Conventional Oxygen Therapy will be administered through Nasal catheter
High-flow nasal oxygen
High Flow Nasal Cannula will be administered
Supraglottic jet oxygenation and ventilation
Nasal jet tube will be administered
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital of Guangzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liya Lu
associate chief physician
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20230618
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.